Encompass Health Corp/ US29261A1007 /
2024-05-16 7:12:26 PM | Chg. -1.23 | Volume | Bid7:21:20 PM | Ask7:21:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
85.83USD | -1.41% | 7,618 Turnover: 327,868.54 |
85.69Bid Size: 1 | 86.15Ask Size: 1 | 8.66 bill.USD | 0.70% | 24.50 |
Assets
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,310.1000 | 1,391.8000 | 1,517.1000 | 1,634.8000 | 1,959.3000 | ||||||
Intangible Assets | 419.4000 | 411.3000 | 403.1000 | 443.4000 | 476.3000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | 4,191.5000 | 4,512.9000 | 5,324.9000 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 410.5000 | 443.8000 | 472.1000 | 467.7000 | 506.1000 | ||||||
Cash and Cash Equivalents | 61.6000 | 40.5000 | 54.4000 | 69.2000 | 94.8000 | ||||||
Current Assets | 598.7000 | 654.5000 | 702.2000 | 662.1000 | 755.8000 | ||||||
Total Assets | 4,606.1000 | 4,681.9000 | 4,893.7000 | 5,175 | 6,080.7000 |
Liabilities
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 61.6000 | 68.3000 | 78.4000 | 90 | 94.6000 | ||||||
Long-term debt | 3,134.7000 | 2,979.3000 | 2,545.4000 | 2,478.6000 | 3,023.3000 | ||||||
Liabilities to Banks | 3,134.7000 | 2,979.3000 | 2,545.4000 | 2,478.6000 | 3,023.3000 | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 3,826.8000 | 3,753.2000 | 3,469.1000 | 3,618 | 4,387.6000 | ||||||
Share Capital | 1.1000 | 1.1000 | 1.1000 | 1.1000 | 1.1000 | ||||||
Total Equity | 779.3000 | 928.7000 | 1,424.6000 | 1,557 | 1,693.1000 | ||||||
Minority Interests | 167.9000 | 192.8000 | 242.9000 | 280.3000 | 340.9000 | ||||||
Total liabilities equity | 4,606.1000 | 4,681.9000 | 4,893.7000 | 5,175 | 6,080.7000 |
Income Statement
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3,115.7000 | 3,707.2000 | 3,971.4000 | 4,277.3000 | 4,605 | ||||||
Depreciation (total) | 139.7000 | 172.6000 | 183.8000 | 199.7000 | 218.7000 | ||||||
Operating Result | - | - | - | - | - | ||||||
Interest Income | 142.9000 | 172.1000 | 154.4000 | 147.3000 | 159.7000 | ||||||
Income Before Taxes | 395.6000 | 482 | 496.4000 | 493.2000 | 562.3000 | ||||||
Income Taxes | 141.9000 | 163.9000 | 160.6000 | 118.9000 | 115.9000 | ||||||
Minority Interests Profit | -69.7000 | -70.5000 | -79.1000 | -83.1000 | -87.1000 | ||||||
Net Income | 181.5000 | 247.6000 | 256.3000 | 292.3000 | 358.7000 |
Per Share
Cash Flow
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 484.8000 | 605.5000 | 657.2000 | 762.4000 | 635.3000 | ||||||
Cash Flow from Investing Activities | -1,129.8000 | -245 | -284.5000 | -424.5000 | -657.4000 | ||||||
Cash Flow from Financing | 639.9000 | -381.6000 | -358.8000 | -321.2000 | 48.2000 | ||||||
Decrease / Increase in Cash | -5.1000 | -21.1000 | 13.9000 | 16.7000 | 26.1000 | ||||||
Employees | 34,700 | 35,710 | 29,370 | 30,060 | 31,570 |